Shanghai, China

Hong Pan

This inventor holds 1 USPTO granted patent. Top assignee: Mabwell (Shanghai) Bioscience Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hong Pan. Retrieved from https://idiyas.com/inventor/hong-pan-p9ne5nb5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hong Pan - Innovator in Antibody Research

Introduction

Hong Pan is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of bioscience, particularly in the development of antibodies. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical research.

Latest Patents

Hong Pan holds a patent for the invention titled "ANTI-ST2 ANTIBODY, ENCODING NUCLEIC ACID MOLECULES THEREOF AND METHODS OF USE THEREOF." This patent represents a crucial advancement in the understanding and application of antibodies in therapeutic contexts. He has 1 patent to his name, reflecting his commitment to innovation in the bioscience sector.

Career Highlights

Currently, Hong Pan is employed at Mabwell (Shanghai) Bioscience Co., Ltd. His role at the company allows him to collaborate with other talented professionals in the field. His work is instrumental in driving forward the company's research initiatives and product development.

Collaborations

Hong Pan has worked alongside notable colleagues such as Xinhui Xiong and Yang Zhang. Their collaborative efforts contribute to the innovative environment at Mabwell, fostering advancements in bioscience research.

Conclusion

Hong Pan's contributions to antibody research and his patent achievements highlight his role as an influential inventor in the bioscience industry. His work continues to pave the way for future innovations in medical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…